Complications of COVID19 - D-Dimer, cTnI, cTnT, ΝΤ-proBNP, PCT



As a specialized diagnostic company in hemostasis and sepsis, we would like to share with you views on the affinity of our coagulation tests with the clinical consequences of COVID-19 infection, to emphasize the need to maintain and enhance anticoagulant monitoring of patients as a potential parameter of infection detection-monitoring.



Pneumonia is present in most hospitalized patients with COVID-19 infection and can be developed into sepsis, a known precursor to diffuse intravascular coagulation (DIC). A study by Tang et al, studying changes in coagulation in patients with COVID-19 pneumonia in Yuhan, China, found that 71.4% of those who died and only 0.6% of those who survived showed diffuse intravascular coagulation samples. Based on this result, we can assume that diffuse intravascular coagulation is a common symptom in patients with severe viral pneumonia, which can lead to death. Recognition of the importance of pathological hemostasis during COVID-19 infection prompted the Global Community for Thrombosis and Hemostasis to issue interim guidelines on the detection and management of the associated disorder. In the presence of the patient the d-dimer, prothrombin time, platelet count and fibrinogen should be monitored. The markedly increased D-dimer justifies admission to the hospital even in the absence of other serious symptoms, as it already means increased thrombin production. These hemostasis parameters should be monitored once or twice a day, as worsening of the results indicates the need for a more aggressive therapeutic approach.


Based on the above, it seems that the measurement of hemostasis parameters such as PT, APTT, Fibrinogen and D-DIMER as well as the parameter of Procalcitonin for the sepsis (available from our company), can be checked in the phase of detection-monitoring of infection by COVID-19. Our company has PT, APTT, Fibrinogen, D-DIMER, cTnI, cTnT, NT-proBNP and Procalcitonin (PCT) hemostasis reagents applied to various analyzers such as OPTION/Thrombotimer, Thrombolyzer, Coadata, FIA 8000, GETEIN 1100. Many of these models are already installed in Health Centers, Hospitals, Clinics, Private Laboratories. Aware of our responsibility, let us invite you to join the common fight against the virus by intensifying the PT, APTT, Fibrinogen, D-DIMER, cTnI, cTnT, NT-proBNP and Procalcitonin tests.




Diachel Α.Ε.

Diachel Α.Ε.


Diachel Α.Ε.